Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prediction factors in the determination of final height in subjects born small for gestational age.
Leger J, Limoni C, Collin D, Czernichow P. Leger J, et al. Among authors: limoni c. Pediatr Res. 1998 Jun;43(6):808-12. doi: 10.1203/00006450-199806000-00015. Pediatr Res. 1998. PMID: 9621992
Growth hormone treatment before the age of 4 years prevents short stature in young girls with Turner syndrome.
Linglart A, Cabrol S, Berlier P, Stuckens C, Wagner K, de Kerdanet M, Limoni C, Carel JC, Chaussain JL; French Collaborative Young Turner Study Group. Linglart A, et al. Among authors: limoni c. Eur J Endocrinol. 2011 Jun;164(6):891-7. doi: 10.1530/EJE-10-1048. Epub 2011 Mar 11. Eur J Endocrinol. 2011. PMID: 21398400 Clinical Trial.
Prediction of the outcome of growth at 2 years of age in neonates with intra-uterine growth retardation.
Leger J, Limoni C, Czernichow P. Leger J, et al. Among authors: limoni c. Early Hum Dev. 1997 May 28;48(3):211-23. doi: 10.1016/s0378-3782(96)01855-5. Early Hum Dev. 1997. PMID: 9154413
.) = 2.10; 95% C.I. = 1.06-4.14), the greater the difference (for each S.D.) between birth length (SDS) and target height (SDS) (O.R. = 1.93; 95% C.I. = 1.40-2.66) and although as a borderline significant factor, maternal tobacco consumption (O.R. = 1.58; C.I …
.) = 2.10; 95% C.I. = 1.06-4.14), the greater the difference (for each S.D.) between birth length (SDS) and target height (SDS) (O.R. …
Growth curves in untreated Ullrich-Turner syndrome: French reference standards 1-22 years.
Sempé M, Hansson Bondallaz C, Limoni C. Sempé M, et al. Among authors: limoni c. Eur J Pediatr. 1996 Oct;155(10):862-9. doi: 10.1007/BF02282835. Eur J Pediatr. 1996. PMID: 8891555
A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.
Rappaport R, Mugnier E, Limoni C, Crosnier H, Czernichow P, Leger J, Limal JM, Rochiccioli P, Soskin S. Rappaport R, et al. Among authors: limoni c. J Clin Endocrinol Metab. 1997 Feb;82(2):452-6. doi: 10.1210/jcem.82.2.3756. J Clin Endocrinol Metab. 1997. PMID: 9024235 Clinical Trial.
A noncomparative multicenter prospective study included 49 children (22 girls and 27 boys) with isolated GH deficiency (n = 19) or multiple pituitary hormone deficiency (n = 30) treated with daily s.c. injections (0.6 U/kg.week) for 3-5 yr. ...
A noncomparative multicenter prospective study included 49 children (22 girls and 27 boys) with isolated GH deficiency (n = 19) or multiple …
Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
Zenaty D, Garel C, Limoni C, Czernichow P, Léger J. Zenaty D, et al. Among authors: limoni c. Clin Endocrinol (Oxf). 2003 May;58(5):647-52. Clin Endocrinol (Oxf). 2003. PMID: 12699449
The greater incidence of small-for-gestational-age newborns after gonadotropin-stimulated in vitro fertilization with a supraphysiological estradiol level on ovulation trigger day.
Kohl Schwartz AS, Mitter VR, Amylidi-Mohr S, Fasel P, Minger MA, Limoni C, Zwahlen M, von Wolff M. Kohl Schwartz AS, et al. Among authors: limoni c. Acta Obstet Gynecol Scand. 2019 Dec;98(12):1575-1584. doi: 10.1111/aogs.13691. Epub 2019 Aug 11. Acta Obstet Gynecol Scand. 2019. PMID: 31338840 Free PMC article.
Beneficial effects of a semi-intensive stroke unit are beyond the monitor.
Cereda CW, George PM, Pelloni LS, Gandolfi-Decristophoris P, Mlynash M, Biancon Montaperto L, Limoni C, Stojanova V, Malacrida R, Städler C, Bassetti CL. Cereda CW, et al. Among authors: limoni c. Cerebrovasc Dis. 2015;39(2):102-9. doi: 10.1159/000369919. Epub 2015 Jan 23. Cerebrovasc Dis. 2015. PMID: 25634579 Free article.
Tolerability and acceptance of prolonged low/delayed mitoxantrone regimens in patients with worsening multiple sclerosis.
Zecca C, Petrini L, Limoni C, Staedler C, Gobbi C. Zecca C, et al. Among authors: limoni c. Eur Neurol. 2011;65(1):40-5. doi: 10.1159/000323013. Epub 2010 Dec 22. Eur Neurol. 2011. PMID: 21196739
Sleep-disordered breathing in acute ischemic stroke and transient ischemic attack: effects on short- and long-term outcome and efficacy of treatment with continuous positive airways pressure--rationale and design of the SAS CARE study.
Cereda CW, Petrini L, Azzola A, Ciccone A, Fischer U, Gallino A, Györik S, Gugger M, Mattis J, Lavie L, Limoni C, Nobili L, Manconi M, Ott S, Pons M, Bassetti CL. Cereda CW, et al. Among authors: limoni c. Int J Stroke. 2012 Oct;7(7):597-603. doi: 10.1111/j.1747-4949.2012.00836.x. Epub 2012 Jul 19. Int J Stroke. 2012. PMID: 22812731 Clinical Trial.
41 results
Jump to page
Feedback